Xiaofei Han Han

Dr. Xiaofei Han Han

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2024 in Phytomedicine
Verified
Journal Article
Closed access
LDLisha Du
Lisha Du
JCJun Chen
Jun Chen
JYJianyi Yan
Jianyi Yan
HXHuiwen Xie
Huiwen Xie
LWLongxing Wang
Longxing Wang
YWYadong Wang
Yadong Wang

12 August 2025 in Neurochemistry International
Verified
Journal Article
Closed access
DPDan Pu
Dan Pu
YJYe Jin
Ye Jin
LWLongxing Wang
Longxing Wang
RWRenjun Wang
Renjun Wang
LLLingyu Li
Lingyu Li
XHXiaofei Han Han
Xiaofei Han Han

2 June 2025 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
LDLisha Du
Lisha Du
BWBenjie Wang
Benjie Wang
XWXinyi Wang
Xinyi Wang
LWLongxing Wang
Longxing Wang
RWRenjun Wang
Renjun Wang
YWYadong Wang
Yadong Wang
Silica nanoparticles (SiO2 NPs) are widely used in the food and pharmaceutical industries and dramatically increase the health risks associated with gastrointestinal exposure. However, the neurotoxicological effects and mechanisms of exposure to SiO2 NPs and their relationship with the gut microbiome require further in-depth investigation. Here, we performed a systematic assessment of the toxicity of gavage containing 20 nm SiO2 NPs to C57BL/6 J mice. After 14 weeks administration, we comprehensively discovered that gastrointestinal exposure to SiO2 NPs led to mice Alzheimer’s disease (AD)-like neurotoxicity, including Aβ accumulation, cognitive impairment, oxidative stress burden, and neuroinflammation, which was microbiota-gut-brain axis-dependent and proven using a low-load gut-bacteria experiment and antibiotic treatment. Mechanistically, gastrointestinal exposure to SiO2 NPs disrupted intestinal homeostasis. Specifically, the total faecal short-chain fatty acid (SCFA) levels were reduced as analysed by 16S rRNA gene sequencing and liquid chromatography mass-spectrometry (LC–MS) analysis. The reduced SCFA content damaged the integrity of gut-brain axis by increasing gut permeability, which may have caused metabolite redistribution, brain basement membrane dissolution, activated the neuroinflammation signalling pathway TLR4/NF-κB, and interfered with HDAC3 and HDAC1/OGG1 pathways. We showed for the first time that gastrointestinal exposure to SiO2 NPs depends on the gut microbiome and causes neurological and cognitive impairment via gut-brain axis information transmission. These findings suggest that the gut microbiota, as a mediator between intestinal and brain information communications, contributes to gastrointestinal exposure to SiO2 NPs-induced neurotoxicity. The health risks of exposure to SiO2 NPs should be recognised, and addressing strategies should be extensively reconsidered.

4 July 2022 in Chinese Journal of Chromatography
Verified
Journal Article
Open access
ZMZhanjun Ma
Zhanjun Ma
ZLZhenguo Li
Zhenguo Li
HWHuan Wang
Huan Wang
RWRenjun Wang
Renjun Wang
XHXiaofei Han Han
Xiaofei Han Han
Colon cancer ( CC) is one of the most common malignant tumors worldwide. As there are no effective biomarkers for the early diagnosis and intervention tracking, the incidence of CC is increasing every year. Cholesterol is an important component of cell membrane, and it has been shown to be associated with CC. Oxysterol is an oxidized derivative of cholesterol, which plays an important role in many malignant tumors. In this study, liquid chromatography-tandem mass spectrometry ( LC-MS/MS) was used to determine serum cholesterol and ten oxysterol metabolites related to cholesterol in CC patients and healthy controls, and qualitative and quantitative analyses were carried out. Raw data were processed and analyzed using GraphPad Prism 8. 3. 0 and the MetaboAnalyst 5.0 platform ( https ; // www. metaboanalyst. ca/ MetaboAnalyst/ModuleView.xhtml). To perform the independent sample t-test, it was necessary to ensure that all the sample data followed a normal distribution; therefore , the normal distribution test was performed in advance. The Mann-Whitney U test, which is a nonparametric test, was adopted for samples without a normal distribution. For the processed data, we used the statistical analysis function module of the MetaboAnalyst 5. 0 platform to perform partial least-square discriminant analysis ( PLS-DA ) and orthogonal partial least-square discriminant analysis ( OPLS-DA). Both PLS-DA and OPLS-DA are supervised discriminant analysis methods. The OPLS-DA model is based on the PLS-DA model and eliminates variables that are unrelated to the experiment. In both models, the samples from the two groups were well separated by the score plot. In the PLS-DA model, the horizontal and vertical coordinates of the score plot represent the interpretation rates of the principal components of the model. The horizontal coordinates show the differences between groups , and the vertical coordinates show the differences within groups. In addition to the score plot in the PLS-DA model, another crucial factor is variable importance in the projection ( VIP). When VIP>1 , the compound makes an important contribution to the model and is also used as a criterion for screening differential metabolites. Based on 10-fold cross-validation ( CV ) of the PLS-DA model, the performance of the model was the best when the number of components was three. To avoid overfitting of the data, three metabolic markers were selected by using not only the VIP values of metabolites of the PLS-DA model, but also the optimal compositions and K-mean clusters. The three biomarkers were 4 beta-hydroxycholesterol ( 4 beta-OHC ) , cholestane-3 beta, 5 alpha , 6 beta-triol ( Triol) , and cholesterol. A receiver operating characteristic ( ROC) curve was constructed. The area under the curve ( AUC) was generally between 0. 5 and 1. 0. In the case of AUC>0. 5 , the closer the AUC is to 1, the better is the performance of the model. In this study, the area under the ROC curve constructed jointly by the three metabolic markers was 0. 998 , indicating that their combined ability to predict CC was strong and that the diagnostic performance was excellent. In addition, to understand the role of the three metabolic markers in the pathogenesis of CC , the genes associated with the metabolic markers were identified using GeneCards ( https : //www.genecards.org/) . Finally, 110 genes were identified. Gene ontology ( GO ) enrichment and Kyoto Encyclopedia of Genes and Genomes ( KEGG) were used to analyze the biological processes , metabolic pathways , and possible roles in the body. GO enrichment showed that the three markers are mainly distributed in the endoplasmic reticulum lumen and coated vesicles, and they are mainly involved in biological processes such as cholesterol metabolism, transportation, and low-density lipoprotein particle remodeling. Their molecular functions are cholesterol transfer activity and low-density lipoprotein particle receptor binding. KEGG pathway analysis showed that biomarkers are enriched in steroid biosynthesis, PPAR ( peroxisome proliferator-activated receptor) signaling pathways , and ABC ( ATP-binding cassette) transport pathways. The results of this study are helpful to understand the role of cholesterol and oxysterol in the pathogenesis of CC and to elucidate the pathogenesis of CC.

14 July 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
GZGuifeng Zhang
Guifeng Zhang
YDYanjie Dou
Yanjie Dou
HXHuiwen Xie
Huiwen Xie
DPDan Pu
Dan Pu
LWLongxing Wang
Longxing Wang
XHXiaofei Han Han
Xiaofei Han Han
Background: Oligopeptides from sea cucumber eggs (SCEPs) are rarely studied for their neuroprotective effects. Methods: Therefore, we prepared SCEPs via simulated gastrointestinal digestion and then administered them to an Alzheimer’s disease (AD) mouse model via gavage. Behavior tests, gut–brain histopathology and fecal microbiota transplantation (FMT) experiments were conducted, and gut microbiota and metabolite short-chain fatty acids (SCFAs) were evaluated via 16sRNA gene sequencing and LC-MS. Results: The results showed that both the SCEP and FMT groups experienced improvements in the cognitive impairments of AD and showed reduced levels of Aβ, P-Tau, GFAP, and NFL in the brain, especially in the hippocampus. SCEP remodeled the gut microbiota, increasing the relative abundances of Turicibacter and Lactobacillus by 2.7- and 4.8-fold compared with the model at the genus level. In the SCEP and FMT treatments, four SCFA-producing bacteria obtained from gut microbiota profiling showed consistent trends, indicating that they may be involved in mediating the neuroprotective effects of SCEP. Mechanically, SCEP regulated the SCFA distribution in feces, blood, and the brain, greatly increased the content of SCFAs in the brain up to 2000 μg/mg, eased gut–brain barrier dysfunction, inhibited HDAC3 overexpression, and upregulated BDNF/NT3 levels. Conclusions: This study provides a promising candidate for preventing AD and a reference for applying SCEP.

5 October 2026 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
DPDan Pu
Dan Pu
JWJu Wu
Ju Wu
YDYanjie Dou
Yanjie Dou
WZWei Zhang
Wei Zhang
LWLongxing Wang
Longxing Wang
XHXiaofei Han Han
Xiaofei Han Han
Gut-brain axis dysfunction contributes to Alzheimer’s disease (AD) beyond amyloid/tau pathology, yet it remains unclear whether oral melatonin (MT) a